The last decade has witnessed a flowering of interest in the history of women and cancer, alongside studies on the history of cancer and related topics.(1) While there might be historical trends that explain the attention paid to certain topics in medical history at particular times, the literature on the history of cancer deals with an inherently controversial disease
Psychoactive drug restrictions and prohibitions have typically followed a reactionary pattern. From tobacco to LSD, the introduction of novel drugs has prompted therapeutic experimentation. Officials showed little concern until these substances also became popular recreational intoxicants.
In the blurb to The Story of Pain, Joanna Bourke provocatively asks 'Everyone knows what pain is, surely?' Every sentient person will experience a diverse range of pains throughout their lifetimes.
The history of emotions, a rocket taking off according to Jan Plamper, seems to be screaming ‘know thyself!’ at psychology in all its various forms, but most specifically at neuroscience. The development of a hard science of emotions has involved, with every step ‘forward’, the forgetting of the previous step.
Ten years after its publication, A History remains relevant. The epidemic continues to rage. The context of its historical and relational trajectories continues to shape both its evolution and the responses to it.
From a comparative perspective the health system of the United States has a history that is both representative and idiosyncratic.
In the latest of our occasional Reviews in History podcast series, Dr Jordan Landes talks to Professor Jan Plamper about his new work on the history of emotions, a subject which he has memorably described as a 'rocket taking off'.
Jan Plamper is Professor of History at Goldsmiths, University of London.
At the start of the monograph, McMillen points out that in the first two decades of the 21st century, one billion people will become infected with TB. The WHO’s Stop TB Strategy addresses TB’s synergistic relationship with HIV/AIDS as well as drug-resistant TB.